144 related articles for article (PubMed ID: 7829400)
21. Urokinase binding to laminin-nidogen. Structural requirements and interactions with heparin.
Stephens RW; Aumailley M; Timpl R; Reisberg T; Tapiovaara H; Myöhänen H; Murphy-Ullrich J; Vaheri A
Eur J Biochem; 1992 Aug; 207(3):937-42. PubMed ID: 1499567
[TBL] [Abstract][Full Text] [Related]
22. Urokinase and the urokinase receptor: association with in vitro invasiveness of human bladder cancer cell lines.
Hudson MA; McReynolds LM
J Natl Cancer Inst; 1997 May; 89(10):709-17. PubMed ID: 9168186
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of metastasis of Lewis lung carcinoma by urinary trypsin inhibitor in experimental and spontaneous metastasis models.
Kobayashi H; Shinohara H; Fujie M; Gotoh J; Itoh M; Takeuchi K; Terao T
Int J Cancer; 1995 Nov; 63(3):455-62. PubMed ID: 7591248
[TBL] [Abstract][Full Text] [Related]
24. [Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].
Kobayashi H
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):623-32. PubMed ID: 8808830
[TBL] [Abstract][Full Text] [Related]
25. Effects of synthetic peptides and protease inhibitors on the interaction of a human ovarian cancer cell line (NIH:OVCAR-3) with a reconstituted basement membrane (Matrigel).
Kanemoto T; Martin GR; Hamilton TC; Fridman R
Invasion Metastasis; 1991; 11(2):84-92. PubMed ID: 1917387
[TBL] [Abstract][Full Text] [Related]
26. Interaction of fucoidan with proteases and inhibitors of coagulation and fibrinolysis.
Minix R; Doctor VM
Thromb Res; 1997 Sep; 87(5):419-29. PubMed ID: 9306616
[TBL] [Abstract][Full Text] [Related]
27. Preparation of aminated fucoidan and its evaluation as an antithrombotic and antilipemic agent.
Soeda S; Ohmagari Y; Shimeno H; Nagamatsu A
Biol Pharm Bull; 1994 Jun; 17(6):784-8. PubMed ID: 7951138
[TBL] [Abstract][Full Text] [Related]
28. Analysis of the in vitro inhibition of mammary adenocarcinoma cell adhesion by sulphated polysaccharides.
Liu JM; Haroun-Bouhedja F; Boisson-Vidal C
Anticancer Res; 2000; 20(5A):3265-71. PubMed ID: 11062752
[TBL] [Abstract][Full Text] [Related]
29. [4-acetamidophenyl retinoate (4-APR) inhibits reconstituted basement membrane invasion by tumor cells and its mechanism].
Shi B; Han R
Zhonghua Zhong Liu Za Zhi; 1997 May; 19(3):196-9. PubMed ID: 10920895
[TBL] [Abstract][Full Text] [Related]
30. Effect of fucoidan on fibroblast growth factor-2-induced angiogenesis in vitro.
Matou S; Helley D; Chabut D; Bros A; Fischer AM
Thromb Res; 2002 May; 106(4-5):213-21. PubMed ID: 12297128
[TBL] [Abstract][Full Text] [Related]
31. Reconstituted basement membrane (matrigel) and laminin can enhance the tumorigenicity and the drug resistance of small cell lung cancer cell lines.
Fridman R; Giaccone G; Kanemoto T; Martin GR; Gazdar AF; Mulshine JL
Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6698-702. PubMed ID: 2168554
[TBL] [Abstract][Full Text] [Related]
32. Inhibitory effect of fucoidan on the adhesion of adenocarcinoma cells to fibronectin.
Liu JM; Bignon J; Haroun-Bouhedja F; Bittoun P; Vassy J; Fermandjian S; Wdzieczak-Bakala J; Boisson-Vidal C
Anticancer Res; 2005; 25(3B):2129-33. PubMed ID: 16158954
[TBL] [Abstract][Full Text] [Related]
33. Affinity of low molecular weight fucoidan for P-selectin triggers its binding to activated human platelets.
Bachelet L; Bertholon I; Lavigne D; Vassy R; Jandrot-Perrus M; Chaubet F; Letourneur D
Biochim Biophys Acta; 2009 Feb; 1790(2):141-6. PubMed ID: 19026722
[TBL] [Abstract][Full Text] [Related]
34. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane.
Liotta LA; Goldfarb RH; Brundage R; Siegal GP; Terranova V; Garbisa S
Cancer Res; 1981 Nov; 41(11 Pt 1):4629-36. PubMed ID: 6458354
[TBL] [Abstract][Full Text] [Related]
35. Effect of oversulfated dermatan sulfate derivatives on platelet aggregation.
Maaroufi RM; Giordano P; Triadou P; Tapon-Bretaudière J; Dautzenberg MD; Fischer AM
Thromb Res; 2007; 120(4):615-21. PubMed ID: 17222891
[TBL] [Abstract][Full Text] [Related]
36. Effect of Oversulfation on the Composition, Structure, and In Vitro Anti-Lung Cancer Activity of Fucoidans Extracted from
Hsiao HH; Wu TC; Tsai YH; Kuo CH; Huang RH; Hong YH; Huang CY
Mar Drugs; 2021 Apr; 19(4):. PubMed ID: 33921340
[TBL] [Abstract][Full Text] [Related]
37. Detection of matrix metalloproteinases (MMP), tissue inhibitor of metalloproteinase-2, urokinase and plasminogen activator inhibitor-1 within matrigel and growth factor-reduced matrigel basement membrane.
Gillette KM; Forbes K; Sehgal I
Tumori; 2003; 89(4):421-5. PubMed ID: 14606648
[TBL] [Abstract][Full Text] [Related]
38. Retinoic acid inhibition of human melanoma cell invasion through a reconstituted basement membrane and its relation to decreases in the expression of proteolytic enzymes and motility factor receptor.
Hendrix MJ; Wood WR; Seftor EA; Lotan D; Nakajima M; Misiorowski RL; Seftor RE; Stetler-Stevenson WG; Bevacqua SJ; Liotta LA
Cancer Res; 1990 Jul; 50(13):4121-30. PubMed ID: 2162253
[TBL] [Abstract][Full Text] [Related]
39. Effect of native fucoidan, sulfated fucoidan, heparin and 6-aminohexanoic acid on the activation of glutamic-plasminogen by urokinase: role of NaCl.
Hall G; Lang D; Qiu X; Doctor V
Blood Coagul Fibrinolysis; 2006 Jun; 17(4):277-81. PubMed ID: 16651870
[TBL] [Abstract][Full Text] [Related]
40. Effect of hepatocyte growth factor on invasion of prostate cancer cell lines.
Fujiuchi Y; Nagakawa O; Murakami K; Fuse H; Saiki I
Oncol Rep; 2003; 10(4):1001-6. PubMed ID: 12792760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
